Investing In Tomorrow's CNS Breakthroughs With Breyer Capital's Bret Bostwick, M.D.

✨ AI Summary

Bret Bostwick discusses his journey from medical geneticist to biotech investor.
He shares insights on CNS drug development challenges and AI's role.
Lessons learned about genetically validated targets and team culture are highlighted.

Guests on This Episode

Oct 12, 2026 · 0:49:23

Oct 8, 2026 · 0:24:46

Oct 7, 2026 · 0:40:00

Oct 5, 2026 · 0:59:52